Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Lo Herma Resource Drilling Timing Confirmed October 2, 2025 Triumph Gold Updates Shareholders on Operations, Engages Market... May 10, 2025 Cameco, Kazatomprom Production Cuts Stoke Uranium Market Tightness August 30, 2025 ARR advances permitting at Cowboy State Mine May 28, 2025 Ericsson, Rogers Launch Canada’s First Underground 5G Network... June 21, 2025 Locksley Qualifies for Trading on U.S. OTCQX Market October 13, 2025 Nextech3D.ai: Disrupting the Global Events Management Industry with... November 5, 2025 Mart Wolbert: Uranium Prices, Supply, Demand — What’s... September 11, 2025 Phase 1 Drill Program – Operational and Geological... May 28, 2025 Silver Price at New Base, What Comes Next?... July 15, 2025